Cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe

Teng‐Yu Gao, Yuting Tao, Haoyang Li, Xin Liu, Yu-Tong Ma, Hui‐Jun Li, Chen‐Yang Xian‐Yu, Nian‐Jia Deng, Wei‐Dong Leng, Jie Luo, Chao ZhangJournal of Global Health 2024 · DOI

TL;DR

This study systematically analyzes cancer burden and risk factors in China's elderly population (55+) from 1990-2019, comparing it to the US and Western Europe. While China has made strides in controlling some cancers, lung, colorectal, pancreatic, and breast cancers are on the rise, driven by economic development and lifestyle changes, highlighting the urgent need for targeted prevention strategies.

What Problem Does This Paper Address?

The paper addresses the growing concern of cancer burden in China, particularly among its rapidly aging population. While global cancer trends are well-documented, understanding the specific trajectory and risk factors within China's unique socio-economic context, and how it compares to developed nations like the US and Western Europe, is crucial for effective public health policy. The authors aim to identify shifts in cancer patterns, highlight disparities, and pinpoint key risk factors to inform future prevention and control efforts, especially in light of China's rapid economic development and associated lifestyle changes.

Methods

The researchers employed a systematic analysis using data from the Global Burden of Disease (GBD) 2019 database. They extracted information on 29 specific cancers for individuals aged 55 and above in China, the USA, and Western Europe, covering the period from 1990 to 2019. Key metrics analyzed included incident cases, deaths, and disability-adjusted life years (DALYs). To compare trends and characteristics, they calculated age-standardized incidence rates (ASIR), age-standardized death rates (ASDR), and age-standardized DALY rates (ASDR). The average annual percentage change (AAPC) was used to assess the trend of these rates over the 30-year period. Risk factor analysis was also conducted, examining the contribution of various factors to cancer burden.

Datasets

The primary dataset used in this study is the Global Burden of Disease (GBD) 2019 database. This comprehensive dataset provides estimates for disease burden, including incident cases, deaths, DALYs, and prevalence, for numerous causes across 204 countries and territories, categorized by age, sex, and year. The study specifically utilized data for 29 distinct cancer types and 69 specific risk factors. No new datasets were introduced by the authors.

Key Insights and Ideas

  • Shifting Cancer Landscape: While China has successfully reduced the burden of stomach, liver, and esophageal cancers, there's a concerning rise in lung, colorectal, pancreatic, and breast cancers, mirroring the impact of economic development and changing lifestyles.
  • Gender Disparity Widening: The cancer burden is significantly higher in men than women, and this gap is widening, with smoking being a major driver for many male-specific cancer increases.
  • Smoking Remains a Critical Threat: Despite tobacco control efforts, smoking prevalence, especially among men, remains high in China, directly contributing to the increasing burden of lung cancer and other related malignancies.
  • Dietary Risks Persist: While the impact of dietary risks is decreasing, certain factors like low fruit intake, low whole grains, low calcium, and high sodium remain significant contributors to cancer burden.
  • Environmental Pollution's Growing Role: Ambient particulate matter pollution is emerging as a significant and increasing risk factor, particularly for lung cancer.
  • Progress in Some Areas, Lagging in Others: China has made notable progress in controlling certain cancers like liver cancer (linked to hepatitis B vaccination efforts), but lags behind the US and Western Europe in controlling lung and colorectal cancers, which are increasing in China while declining in these developed regions.

Key Results

  • Overall Burden Increase: In China, the number of incident cancer cases among those aged 55+ in 2019 was three times that of 1990, with deaths and DALYs nearly doubling.
  • Top Cancers by DALYs (2019): Lung cancer (13,444,500 DALYs), stomach cancer (7,303,900 DALYs), esophageal cancer (4,633,500 DALYs), colon and rectum cancer (4,386,500 DALYs), liver cancer (2,915,100 DALYs), and pancreatic cancer (2,028,400 DALYs) were the most burdensome.
  • Lung Cancer Dominance: Lung cancer has become the leading cause of cancer death in China in 2019, with nearly twice the number of deaths as stomach cancer.
  • Breast Cancer Surge in Women: The incidence rate of breast cancer in women aged 55+ more than doubled between 1990 and 2019, making it the second highest cancer by incident cases in this age group.
  • Comparative Rates: While overall age-standardized DALY rates and ASDRs were similar across China, the USA, and Western Europe, showing a downward trend, China had higher rates for liver, nasopharyngeal, esophageal, stomach, and cervical cancers compared to the US and Western Europe. Conversely, lung and colorectal cancer rates increased in China while decreasing in the US and Western Europe.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of Granularity: The GBD data is country-level, preventing analysis of provincial, urban, or rural variations, which are significant in China. This limits a deeper understanding of localized cancer characteristics and disparities.
  • Data Accuracy for Early Years: Early data might be affected by the level of available screening and diagnostic capabilities, potentially leading to underestimation of true cancer burden and bias in comparisons.
  • Comparison Bias: Differences in screening levels and standards between regions could affect the direct comparison of cancer control effectiveness.

Future work should focus on:

  • Addressing Key Risk Factors: Urgent interventions are needed for smoking cessation and promoting healthier dietary habits.
  • Balancing Development and Health: Future cancer prevention efforts must balance economic development with public health, improving the living environment and promoting healthy lifestyles.
  • Expanding Screening: Increasing the scope and accessibility of cancer screening programs, particularly for key cancers and in underserved areas, is crucial.
  • Targeted Interventions: Developing policies that consider the evolving cancer spectrum and implementing targeted interventions for specific populations and cancers are essential.

Summary updated

Abstract

Over the past 30 years, China had made progress in controlling stomach, oesophageal, and liver cancer. However, lung, colon, rectum, pancreatic, and breast cancers had become more prevalent, having risen alongside economic development. The risks of smoking and dietary were major issues that need to be addressed urgently. The cancer situation in China remains serious; future cancer prevention efforts need to balance economic development with people's physical health, identify key groups, improve the health environment of residents and guide them to live a healthy life, and expand the scope of cancer screening.
BibTeX
@article{gao2024cancer,
  author = {Teng‐Yu Gao and Yuting Tao and Haoyang Li and Xin Liu and Yu-Tong Ma and Hui‐Jun Li and Chen‐Yang Xian‐Yu and Nian‐Jia Deng and Wei‐Dong Leng and Jie Luo and Chao Zhang},
  title = {{Cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe}},
  journal = {Journal of Global Health},
  year = {2024},
  doi = {10.7189/jogh.14.04014},
}
Figure